Comparative cardioprotective effects of cromakalim and diltiazem in ischemic hypertrophied rat hearts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 1 39-1, 1996, Pages

  Grover, Gary J ^a   Dzwonczyk, Steven ^a   Monticello, Thomas M ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

coronary flow; heart; hypertrophy; morphology; myocardial ischemia; spontaneously hypertensive rats

Indexed keywords

CROMAKALIM; DILTIAZEM; LACTATE DEHYDROGENASE; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; HEART HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART WEIGHT; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030040194     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.1.h174     Document Type: Article

References (28)

1. Atwal, K. Modulation of potassium channels by organic molecules. Med. Res. Rev. 12: 569-591, 1992.
2. Auchampach, J. A., M. Maruyama, I. Cavero, and G. J. Gross. The new K channel opener aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. J. Pharmacol. Exp. Ther. 259: 961-967, 1991.
3. Borkon, A. M., M. Jones, J. H. Bell, and J. E. Pierce. Regional myocardial blood flow in left ventricular hypertrophy. An experimental investigation in Newfoundland dogs with congenital subaortic stenosis. J. Thorac. Cardiovasc. Surg. 84: 876-885, 1982.
4. + channels are altered in hypertrophied ventricular myocytes. Am. J Physiol. 255 (Heart Circ. Physiol. 24): H1254-H1258, 1988.
5. + channels from hypertrophied ventricular myocytes. J. Pharmacol. Exp. Ther. 260: 254-260, 1992.
6. Cole, W. C., C. D. McPherson, and D. Sontag. ATP-regulated channels protect the myocardium against ischemia/reperfusion damage. Circ. Res. 69: 571-581, 1991.
7. D'Alonzo, A. J., R. B. Darbenzio, C. S. Parham, and G. J. Grover. Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration. Cardiovasc. Res. 26: 1046-1053, 1992.
8. Falotico, R., J. Keiser, B. Haertlein, W. Cheung, and A. Tobia. Increased vasodilator responsiveness to BRL 34915 in spontaneously hypertensive versus normotensive rats: contrast to nifedipine. Proc. Soc. Exp. Biol. Med. 190: 179-185, 1989.
9. Gross, G. J., and J. A. Auchampach. Blockade of ATP-sensitive potassium channel prevents myocardial preconditioning in dogs. Circ. Res. 70: 223-233, 1992.
10. Grover, G. J., S. Dzwonczyk, and P. G. Sleph. Reduction of ischemic damage in isolated rat hearts by the potassium channel opener RP 52891 Eur. J. Pharmacol. 191: 11-19, 1990.
11. Grover, G. J., J. R. McCullough, D. E. Henry, M. L. Conder, and P. G. Sleph. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J. Pharmacol. Exp. Ther. 251: 98-104, 1991.
12. Grover, G. J., J. Newburger, P. G. Sleph, S. Dzwonczyk, S. C. Taylor, S. Z. Ahmed, and K. S. Atwal. Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides. J. Pharmacol Exp. Ther. 257: 156-162, 1991.
13. Grover, G. J., and P. G. Sleph. Dissociation of cardiodepression and cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine. J. Cardiovasc. Pharmacol. 14: 331-340, 1989.
14. 1-receptors. Circulation 86: 1310-1316, 1992.
15. Holtz, J., W. V. Restorff, P. Bard, and E. Bassenge. Transmural distribution of myocardial blood flow and of coronary reserve in canine left ventricular hypertrophy. Basic Res. Cardiol. 72: 286-292, 1977.
16. Kohya, T., S. Kimura, R. J. Myerburg, and A. L. Bassett. Susceptibility of hypertrophied rat hearts to ventricular fibrillation during acute ischemia. J. Mol. Cell Cardiol. 20: 159-168, 1988.
17. Marchetti, G. N., L. Merlo, V. Noseda, and O. Visioli. Myocardial blood flow in experimental cardiac hypertrophy in dogs. Cardiovasc. Res. 7: 519-527, 1973.
18. McDowell, E. M., and B. F. Trump. Histologic fixatives suitable for diagnostic light and electron microscopy. Arch. Pathol. Lab. Med. 100: 405-414, 1976.
19. McCullough, J. R., D. E. Normandin, M. L. Conder, P. G. Sleph, S. Dzwonczyk, and G. J. Grover. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ. Res. 69: 949-958, 1991.
20. Monticello, T. M. C. Sargent, J. McGill, D. Barton, and G. J. Grover. Amelioration of ischemia/reperfusion injury in isolated rat hearts by the ATP-sensitive potassium channel opener BMS-180448. Cardiovasc. Res. In press.
21. Nolan, S. E., P. Dudeck, J. A. Mannisi, D. E. Bush, and H. F. Weisman. Greater infarct expansion in a chronic left ventricular hypertrophy model: possible mechanism of increased mortality seen in hypertensives with acute myocardial infarction J Am. Coll. Cardiol. 7: 167A, 1986.
22. Sargent, C. A., S. Dzwonczyk, and G. J. Grover. Effect of the potassium channel opener EMD 56431 on globally ischemic rat hearts. Pharmacology 45: 260-268, 1992.
23. Strauss, R. H., E. O. Weinberg, W. M. Vogel, and C. S. Apstein. Hypertrophied myocardium is not more sensitive to ischemic injury (Abstract). J. Am. Coll. Cardiol. 7: 167A, 1986.
24. Toombs, C. F., T. L. Moore, and R. J. Shebuski. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc. Res. 27: 617-622, 1993.
25. Turek, Z., and K. Rakusan. Lognormal distribution of intercapillary distance in normal and hypertrophic rat heart as estimated by the method of concentric circles: its effect on tissue oxygenation. Pfluegers Arch. 391: 17-21, 1981.
26. Van der Laarse, A., L. Hollaar, and L. J. M. Van der Volk. Release of alpha hydroxybutyrate from neonatal rat heart cell cultures exposed to anoxia and reoxygenation: comparison with impairment of structure and function of damaged cardiac cells. Cardiovasc. Res. 13: 345-353, 1979.
27. Wikman-Coffelt, J., W. W. Parmley, and D. T. Mason. The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development. Circ. Res. 45, 697-706, 1979.
28. Wroblewski, F., and J. S. La Due. Lactic dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med. 90: 210-213, 1955.